[Future direction of adjuvant chemotherapy for breast cancer following new risk categories of St. Gallen Consensus]

Nihon Rinsho. 2007 Jun 28:65 Suppl 6:407-13.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / etiology
  • Chemotherapy, Adjuvant
  • Consensus*
  • Drug Administration Schedule
  • Female
  • Humans
  • Risk
  • Risk Assessment
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Trastuzumab